Rhei Rhizoma and Chunghyuldan inhibit pancreatic lipase

Natural Product Sciences

Volumn 9, Issue 1, 2003, Pages 38-43

  Yang, Hyung Kil ^a   Kim, Young Suk ^a   Bae, Hyung Sup ^a   Cho, Ki Ho ^a   Shin, Ji Eun ^a   Kim, Nam Jae ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Antihyperlipidemic activity; Chunghyuldan; Pancreatic lipase; Rhei Rhizoma; Whangryunhaedoktang

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; CHUNGHYULDAN; CORN OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RHUBARB EXTRACT; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRIOLEIN; TYLOXAPOL; UNCLASSIFIED DRUG; WHANGRYUNHAEDOKTANG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ISOLATION; ENZYME INHIBITION; HERBAL MEDICINE; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0037357716     PISSN: 12263907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470-5 (1974).
2. Ballinger, A., Peikin, S. R., Orlistat: its current status as an antiobesity drug. Eur. J. Pharmacol., 440, 109-117 (2002).
3. Carey, M. C., Small, D. M., Bliss, C. M., Lipid digestion and absorption. Annu. Rev. Physiol., 45, 651-677 (1983).
4. Duhault, J., Boulanger, M., Beregi, L., Sicot, N., Bouvier, F. A new type of hyperlipidemic agent comparative assay in rats. Atherosclerosis. 23, 63-72 (1976).
5. Han, L. K., Kimura, Y., Kawashima, M., Takaku, T., Taniyama, T, Hayashi, T., Zheng, Y. N., Okuda, H. Antiobesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obes. 25, 1459-1464 (2001).
6. Hayakawa J, Noda N, Yamada S, Mikami E, Uno K. Studies on physical and chemical quality evaluation of crude drugs preparations. III. Analysis of Gardenia fruits and its preparations. Yakugaku Zasshi. 105, 996-1000 (1985).
7. Hong, N. D., Kim, J. W., Doo, H. K., Kim, N. J., Studies on the efficacy of combined preparation of crude drugs (V)-Effect of "Whangryonhaedok-Tang" on the antiinflammatory, ileum of mice, blood pressure, blood glucose, total cholesterol and antibacterial activity. Kor. J. Pharmacog. 13, 26-32 (1982)
8. Junge, W., "Methods of Enzymatic Analysis," Vol. 4., ed. by Bergmeyer H. U., Verlag Chemie GmbH, Weinheim, 1984, pp. 15-25.
9. Kim, Y. S., Jung, E. A., Chang, J. C., Yang, H. K., Kim, N. J., Cho, C. H., Bae, H. S., Lee, K. S., Kim, D. H. Effect of Daio- Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase. Biol. Pharm. Bull. 25, 1442-1445 (2002).
10. Kusama, H., Nishiyama, M., Ikeda, S., Pharmacological investigation of bezafibrate, a hypolipidemic agent, (I). Effect of bezafibrate on normal and experimental hyperlipidemia in rats. Folia pharmacol. Japon, 92, 175-180 (1988)
11. Mainard, F., Madec, Y., Cholesterol, phospholipid and apo B composition of LDL; Comparison of precipitation and ultracentrifugation methods. Ann. Biol. Clin. 44, 618-623 (1986)
12. Niiho, H., Yamazaki, T., Nakajima, Y., Itoh, H., Takeshita, T., Kinjo, J., Nohara, T. Pharmacological studies on Puerariae Flos. II. The effects of Puerariae Flos on alcohol-induced unusual metabolism and experimental liver injury in mice. Yakugaku Zasshi. 110, 604-11 (1990)
13. Ohshima, Y, Takahashi, K., Hiraga, Y., Shibata, S. Studies on the evaluation of Chinese drug preparations. Determination of sennosides in the drug preparation containing Rhubarb. Shoyakugaku Zasshi. 37, 217-222 (1983).
14. Olsson, A. G., Lang, P. D., Vollmar, J., Effect of bezafibrate during 4,5 years of treatment of hyperlipidemia. Atheroscleosis, 55, 195-199 (1985)
15. Raghavendra, M. P., Prakash, V. Phenylboronic acid - a potent inhibitor of lipase from Oryza stiva. J. Agric. Food Chem. 50, 6037-6041 (2002)
16. Sardesai, V. M., Mannig, J. A., The determination of triglycerides in plasma and tissues. Clin. Chem. 14, 156-158 (1968)
17. Suenaga, T., Shirakawa, T., Harada, N., Tao, C., Yamasaki, M., Komatsu, H., Matsumoto, N., Kida, M., Kawamoto, Y., Murakami, Y., Kakamura, M., Mieno, H., Inoue, M., Kajiyama, G., Mechanism of protective effects of Ouren-Gedoku-To and San'ou-Syanshin-To on the gastric mucosa. Folia pharmacol japon. 98, 319-325 (1991)
18. The Korean Pharmacopia. 7th ed. pp. 721, 766, 778, 779, 781, 1997.
19. Yamamoto, M., Shimura, S., Itoh, Y., Ohsaka, T., Egawa, M., Inoue, S. Antiobesity effects of lipase inhibitor CT-II an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 24, 758-764 (2000)
20. Yoshinaga, S., Kimura, M., Tanaka, A., Tomonaga, M., The effect of Kampo medicine "Oren-gedoku-to" on clinical manifestations and cerebral blood flow in chronic stage of cerebrovascular diseases. J. Med. Pharm. Sco. WAKAN-YAKU, 9, 22-27 (1992)